Search research articles
Contact Us
Filters
Showing results (151-160 of 436) with videos related to
Page
of 44
Sort By:
Haematologica
|
November 6, 2025
Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixed-lineage leukemia and mutated nucleophosmin-1
Valerio Ciaurro, Vassilena Sharlandjieva, Anna Skwarska, et al.
Cancer
|
October 23, 2025
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens
Hagop M Kantarjian, Gautam Borthakur, Naval Daver, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse
Preetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Cancer Research Communications
|
February 23, 2024
Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Jessica L Root, Poonam N Desai, Christopher Ly, et al.
Cancer
|
August 11, 2016
A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase
Koichi Takahashi, Hagop M Kantarjian, Yulong Yang, et al.
Cancer
|
October 20, 2015
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Preetesh Jain, et al.
American Journal of Hematology
|
December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
Paolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Naval Daver, James S Blachly, Armin Ghobadi, et al.
Page
of 44
Search research articles
Search
Showing results (151-160 of 436) with videos related to
Sort By:
Page
of 44
Haematologica
|
November 6, 2025
Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixed-lineage leukemia and mutated nucleophosmin-1
Valerio Ciaurro, Vassilena Sharlandjieva, Anna Skwarska, et al.
Cancer
|
October 23, 2025
A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens
Hagop M Kantarjian, Gautam Borthakur, Naval Daver, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse
Preetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Cancer Research Communications
|
February 23, 2024
Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Jessica L Root, Poonam N Desai, Christopher Ly, et al.
Cancer
|
August 11, 2016
A propensity score matching analysis of dasatinib and nilotinib as a frontline therapy for patients with chronic myeloid leukemia in chronic phase
Koichi Takahashi, Hagop M Kantarjian, Yulong Yang, et al.
Cancer
|
October 20, 2015
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Preetesh Jain, et al.
American Journal of Hematology
|
December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
Paolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Naval Daver, James S Blachly, Armin Ghobadi, et al.
Page
of 44